LINAC2022 - List of Authors (Dyks, L.A.)

Paper	Title	Page
MOPOJO09	A Compact Inverse Compton Scattering Source Based on X-Band Technology and Cavity-Enhanced High Average Power Ultrafast Lasers	44
	A. Latina, R. Corsini, L.A. Dyks, E. Granados, A. Grudiev, V. Musat, S. Stapnes, W. Wuensch CERN, Meyrin, Switzerland E. Cormier CELIA, Talence, France L.A. Dyks Oxford University, Physics Department, Oxford, Oxon, United Kingdom G. Santarelli ILE, Palaiseau Cedex, France
	A high-pulse-current injector followed by a short high-gradient X-band linac is considered as a driver for a compact Inverse Compton Scattering source. We show that using a high-power ultrashort pulse laser operating in burst mode and a Fabry-Pérot enhancement cavity, X-rays with flux values over 10¹³ ph/s and photon energies up to MeV are achievable. The resulting high-intensity and high-energy X-rays allow for various applications, including cancer therapy, tomography, and nuclear waste management. A preliminary conceptual design of such a compact ICS source is presented, together with simulations of the expected performance.
DOI •	reference for this paper ※ https://doi.org/10.18429/JACoW-LINAC2022-MOPOJO09
About •	Received ※ 19 August 2022 — Revised ※ 30 August 2022 — Accepted ※ 01 September 2022 — Issue date ※ 06 September 2022
Cite •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

THPOPA06	Methods for VHEE/FLASH Radiotherapy Studies and High Dose Rate Dosimetry at the CLEAR User Facility	758
THOPA04	use link to see paper's listing under its alternate paper code
	P. Korysko Oxford University, Physics Department, Oxford, Oxon, United Kingdom J.J. Bateman, C.S. Robertson JAI, Oxford, United Kingdom R. Corsini, L.A. Dyks, W. Farabolini, V. Rieker CERN, Meyrin, Switzerland
	The interest for Very High Energy Electron (VHEE) radiotherapy (RT) for cancer treatment recently bloomed, given the present availability of high-gradient accelerator technology for compact, cost effective electron linacs in the 100-200 MeV energy range. Particularly promising is the so called FLASH high dose rate regime, in which cancer cells are damaged while healthy tissue is largely spared. VHEE beams are especially adapted for FLASH RT, given their penetration depth and the high beam current, needed to treat large deep seated tumors. In the CERN Linear Accelerator for Research (CLEAR) facility, a series of unique studies have been initiated on VHEE and FLASH RT issues, in collaboration with several multidisciplinary user groups. In this paper we briefly outline the activities and its main recent results, e.g. on localized dose deposition by beam focusing, and on chemical and biological test to clarify damage mechanisms. We then describe in details the dedicated systems and the techniques adopted - and in large part locally developed by the CLEAR team - in order to satisfy the user requirements, with particular attention to the crucial aspect of high dose rate dosimetry.
	Slides THPOPA06 [1.183 MB]
DOI •	reference for this paper ※ https://doi.org/10.18429/JACoW-LINAC2022-THPOPA06
About •	Received ※ 17 August 2022 — Revised ※ 22 August 2022 — Accepted ※ 31 August 2022 — Issue date ※ 16 October 2022
Cite •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

Paper

Title

Page

A Compact Inverse Compton Scattering Source Based on X-Band Technology and Cavity-Enhanced High Average Power Ultrafast Lasers

44

A. Latina, R. Corsini, L.A. Dyks, E. Granados, A. Grudiev, V. Musat, S. Stapnes, W. Wuensch
CERN, Meyrin, Switzerland
E. Cormier
CELIA, Talence, France
L.A. Dyks
Oxford University, Physics Department, Oxford, Oxon, United Kingdom
G. Santarelli
ILE, Palaiseau Cedex, France

A high-pulse-current injector followed by a short high-gradient X-band linac is considered as a driver for a compact Inverse Compton Scattering source. We show that using a high-power ultrashort pulse laser operating in burst mode and a Fabry-Pérot enhancement cavity, X-rays with flux values over 10¹³ ph/s and photon energies up to MeV are achievable. The resulting high-intensity and high-energy X-rays allow for various applications, including cancer therapy, tomography, and nuclear waste management. A preliminary conceptual design of such a compact ICS source is presented, together with simulations of the expected performance.

DOI •

reference for this paper ※ https://doi.org/10.18429/JACoW-LINAC2022-MOPOJO09

About •

Received ※ 19 August 2022 — Revised ※ 30 August 2022 — Accepted ※ 01 September 2022 — Issue date ※ 06 September 2022

Cite •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

THPOPA06

Methods for VHEE/FLASH Radiotherapy Studies and High Dose Rate Dosimetry at the CLEAR User Facility

758

THOPA04

use link to see paper's listing under its alternate paper code

P. Korysko
Oxford University, Physics Department, Oxford, Oxon, United Kingdom
J.J. Bateman, C.S. Robertson
JAI, Oxford, United Kingdom
R. Corsini, L.A. Dyks, W. Farabolini, V. Rieker
CERN, Meyrin, Switzerland

The interest for Very High Energy Electron (VHEE) radiotherapy (RT) for cancer treatment recently bloomed, given the present availability of high-gradient accelerator technology for compact, cost effective electron linacs in the 100-200 MeV energy range. Particularly promising is the so called FLASH high dose rate regime, in which cancer cells are damaged while healthy tissue is largely spared. VHEE beams are especially adapted for FLASH RT, given their penetration depth and the high beam current, needed to treat large deep seated tumors. In the CERN Linear Accelerator for Research (CLEAR) facility, a series of unique studies have been initiated on VHEE and FLASH RT issues, in collaboration with several multidisciplinary user groups. In this paper we briefly outline the activities and its main recent results, e.g. on localized dose deposition by beam focusing, and on chemical and biological test to clarify damage mechanisms. We then describe in details the dedicated systems and the techniques adopted - and in large part locally developed by the CLEAR team - in order to satisfy the user requirements, with particular attention to the crucial aspect of high dose rate dosimetry.

Slides THPOPA06 [1.183 MB]

DOI •

reference for this paper ※ https://doi.org/10.18429/JACoW-LINAC2022-THPOPA06

About •

Received ※ 17 August 2022 — Revised ※ 22 August 2022 — Accepted ※ 31 August 2022 — Issue date ※ 16 October 2022

Cite •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)